Effect of leukotactin-1 on the protection in vivo of myeloid progenitor cells against cytotoxic chemotherapeutics

Journal of Hematotherapy and Stem Cell Research

Volumn 12, Issue 1, 2003, Pages 107-113

  Kim, Won Y ^a   Broxmeyer, Hal E ^b,c   Han, In Seob ^a   Park, Doo H ^d   Lee, Ki Man ^e   Vinay, Dass S ^f   Kwon, Byoung S ^a,f  

^a University of Ulsan   (South Korea)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WALTHER CANCER INSTITUTE   (United States)

^d Morgam Biotechnology Institute   (South Korea)

^e Ulsan University College of Medicine   (South Korea)

^f LSU EYE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTARABINE; FLUOROURACIL; LEUKOTACTIN 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; BURST FORMING UNIT E; CHEMOTHERAPY; COLONY FORMING UNIT GEMM; COLONY FORMING UNIT GM; CONTROLLED STUDY; DRUG EFFECT; HEMATOPOIETIC CELL; IN VIVO STUDY; MOUSE; MYELOPOIESIS; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTE; RADIOTHERAPY;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; BONE MARROW; CELL NUCLEUS; CHEMOKINES, CC; COLONY-FORMING UNITS ASSAY; CYTARABINE; DNA; FLUOROURACIL; HEMATOPOIETIC STEM CELLS; MACROPHAGE INFLAMMATORY PROTEIN-1; MICE; MICE, INBRED C3H; MODELS, GENETIC; MYELOID PROGENITOR CELLS; RECOMBINANT PROTEINS; STEM CELLS; TIME FACTORS;

EID: 0037294270     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/152581603321210181     Document Type: Article

References (19)

1. Baggiolini M and CA Dahinden CA. (1994). CC chemokines in allergic inflammation. Immunol Today 15:127-133.
2. Kelner SG, J Kennedy, KB Bacon, S Dleyensteuber, DA Largaespada, NA Jenkins, NG Copeland, JF Bazan, KW Moore, TJ Schall, TJ and A Zlotnik. (1994). Lymphotactin: a cytokine that represents a new class of chemokine. Science 266:1395-1399.
3. 3C motif. Nature 385:640-644.
4. + T cells. Science 270:1811-1815.
5. Wolpe SD, G Davatelis, B Sherry, B Beutler, DG Hesse, HT Nguyen, LL Moldawer, CF Nathan, SF Lowry and A Cerami. (1988). Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties. J Exp Med 167:570-581.
6. Graham GJ, EG Wright, R Hewick, SD Wolpe, NM Wilke, D Donaldson, S Lorimore and IB Pragnell. (1990). Identification and characterization of an inhibitor of haemopoietic stem cell proliferation. Nature 344:442-444.
7. Broxmeyer HE, B Sherry, L Lu, S Cooper, K-O Oh, P Tekamp-Olson, BS Kwon and A Cerami. (1990). Enhancing and suppressing effects of recombinant murine macrophage inflammatory proteins on colony formation in vitro by bone marrow myeloid progenitor cells. Blood 76:1110-1116.
8. Broxmeyer HE and CH Kim. (1999). Regulation of hematopoiesis in a sea of chemokine family members with a plethora of redundant activities. Exp Hematol 27:1113-1123.
9. Youn BS, C Mantel and HE Broxmeyer. (2000). Chemokines, chemokine receptors, and hematopoiesis. Immunol Rev 177:150-174.
10. Neote K, D DiGregorio, JY Mak, R Horuk and TJ Schall. (1993). Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor. Cell 72:415-425.
11. Charo I, SJ Myers, A Herman, C Franci, AJ Connolly and SR Coughlin. (1994). Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. Proc Natl Acad Sci USA 91:2752-2756.
12. Kitaura M, T Nakajima, T Imai, S Harada, C Combadiere, HL Tiffany, PM Murphy and O Yoshie. (1996). Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3. J Biol Chem 271:7725-7730.
13. Youn B-S, SM Zhang, EK Lee, DH Park, HE Broxmeyer, PM Murphy, M Locati, JE Pease, KK Kim, K Antol and BS Kwon. (1998). Molecular cloning of leukotactin-1: a novel human β-chemokine, a chemoattractant for neutrophils, monocytes and lymphocytes, and a potent agonist at CC chemokine receptors 1 and 3. J Immunol 159:5201-5205.
14. Youn B-S, IK Jang, HE Broxmeyer, S Cooper, NA Jenkins, DJ Gilbert, NG Copeland, TA Elick, MJ Jr Fraser and BS Kwon. (1995). A novel chemokine, macrophage inflammatory protein-related protein-2, inhibits colony formation of bone marrow myeloid progenitors. J Immunol 155:2661-2667.
15. Youn BS, SM Zhang, HE Broxmeyer, S Cooper, K Antol, M Fraser and BS Kwon. (1998). Characterization of CKβ8 and CKβ8-1: two alternatively spliced forms of human β-chemokine, chemoattractants for neutrophils, monocytes, and lymphocytes, and potent agonists at CC chemokine receptor 1. Blood 91:3118-3126.
16. 2-terminal amino acid residues increases agonistic potency of leukotactin-1 on CC chemokine receptors 1 and 3. J Biol Chem 277:14757-14763.
17. Zhang SM, BS Youn, JL Gao, P Murphy and BS Kwon. (1999). Differential effects of leukotactin-1 and macrophage inflammatory protein-1α on neutrophils mediated by CCRI. J Immunol 162:4938-4942.
18. Broxmeyer HE, DE Williams, S Cooper, RK Shadduck, S Gillis, A Waheed, DL Urdal and DC Bicknell. (1987). Comparative effect in vivo of recombinant murine interleukin-3, natural murine colony stimulating factor-1, and recombinant murine granulocyte-macrophage colony-stimulating factor on myelopoiesis in mice. J Clin Invest 79:721-730.
19. Cooper S and HE Broxmeyer. (1996). Measurement of interleukin-2 and other hematopoietic growth factors such as GM-CSF, G-CSF, M-CSF, erythropoietin and the potent co-stimulatory cytokines steel factor and FH-2 ligand. In: Current Protocols in Immunology. JE Coligan, AM Kruisbeek, DH Margulies, EM Shevach, W Strober and R Coico, eds. John Wiley and Sons, Inc., New York, Suppl 18, pp 6.4.1-6.4.12.